Paclitaxel and sirolimus eluting stents versus bare metal stents: long-term risk of stent thrombosis and other outcomes. From the Western Denmark Heart Registry-Reference-Cited by-同舟云学术

Paclitaxel and sirolimus eluting stents versus bare metal stents: long-term risk of stent thrombosis and other outcomes. From the Western Denmark Heart Registry

Published:2010-04 Issue:8 Volume:5 Page:898-905
ISSN:1774-024X
Container-title:EuroIntervention
language:
Short-container-title:EuroIntervention

Author:

Jensen Lisette,Tilsted Hans,Thayssen Per,Kaltoft Anne,Maeng Michael,Lassen Jens,Hansen Knud,Madsen Morten,Ravkilde Jan,Johnsen Søren,Sørensen Henrik,Thuesen Leif

Publisher

Europa Digital & Publishing

Subject

Cardiology and Cardiovascular Medicine

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Comparative Analysis of Two Biolimus-Eluting Biodegradable Stents: Evaluation of the Equivalence of 6 Months Versus 12 Months of DAPT Following Biolimus-Eluting Stent Implantation in Acute Coronary Syndrome (EQUUS);Journal of Cardiovascular Intervention;2022

2. Real-World Long-Term Clinical Outcomes of Ultrathin Strut Biodegradable Polymer Drug-Eluting Stents in Korean ST-Segment-Elevation Myocardial Infarction (STEMI) Patients with or without Acute Heart Failure Undergoing Primary Percutaneous Coronary Intervention;Journal of Clinical Medicine;2021-12-15

3. Second generation drug-eluting stents: a focus on safety and efficacy of current devices;Expert Review of Cardiovascular Therapy;2021-02-01

4. Are drug-eluting stents safer than bare-metal stents?;The Lancet;2019-06

5. Randomized Prospective Comparison of Everolimus-Eluting vs. Sirolimus-Eluting Stents in Patients Undergoing Percutaneous Coronary Intervention　― 3-Year Clinical Outcomes of the EXCELLENT Randomized Trial ―;Circulation Journal;2018-05-25